In vitro inhibition of tumour necrosis factor-α and interleukin-6 production by intravenous immunoglobulins-Reference-Cited by-同舟云学术

In vitro inhibition of tumour necrosis factor-α and interleukin-6 production by intravenous immunoglobulins

Published:2008-03-12 Issue:4 Volume:89 Page:698-703
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Toungouz Michel,Denys Chantal H.,Groote Donat De,Dupont Etienne

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1995.tb08404.x/fullpdf

Reference22 articles.

1. Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy;Abe;Immunological Reviews,1994

2. Intravenous immunoglobulin therapy for toxic shock syndrome;Barry;Journal of the American Medical Association,1992

3. Fc receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes;Debets;Journal of Immunology,1988

4. Superantigens: biology, immunology, and potential role in disease;Drake;Journal of Clinical Immunology,1992

5. Manipulating the immune system with immune globulin;Dwyer;New England Journal of Medicine,1992

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful Treatment of Steroid-Refractory Checkpoint Inhibitor Myocarditis with Globulin Derived-Therapy: A Case Report and Literature Review;The American Journal of the Medical Sciences;2021-10

2. Application of intravenous immunoglobulin (IVIG) to modulate inflammation in critical COVID-19 – A theoretical perspective;Medical Hypotheses;2021-06

3. Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review;Journal of Interferon & Cytokine Research;2020-12-01

4. The novel polyclonal Ab preparation trimodulin attenuates ex vivo endotoxin-induced immune reactions in early hyperinflammation;Innate Immunity;2019-06-04

5. TBA225, a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigens;Scientific Reports;2019-03-01